Abstract
Objective: To describe the knowledge, attitudes and practices of prenatal care providers in relation to prenatal HIV testing.
Methods: A stratified random sample of 784 family physicians, 200 obstetricians and 103 midwives providing prenatal care in 3 health planning regions in Ontario received a questionnaire.
Results: Response was 622/1087 (57%). Almost half of participants (43%) were not aware of Ontario’s prenatal HIV testing policy. Eighty-five percent of participants reported that they offered or ordered HIV testing for all pregnant women. Sixty-six percent agreed that women should have a choice about whether to test or not, and midwives were more supportive of having an informed consent process than were physicians.
Conclusion: Knowledge about the risks and benefits of prenatal HIV testing needs to be improved, and standards for informed consent should be re-evaluated to achieve the most ethical process with the least complexity.
Résumé
Objectif: Décrire les connaissances, les attitudes et les pratiques des fournisseurs de soins prénatals à l’égard du dépistage anténatal du VIH.
Méthode: Nous avons envoyé un questionnaire à un échantillon stratifié aléatoire de 784 médecins de famille, 200 obstétriciens et 103 sages-femmes offrant des soins prénatals dans trois régions de planification sanitaire de l’Ontario.
Résultats: Le taux de réponse était de 622/1 087 (57 %). Près de la moitié des participants (43 %) ne connaissaient pas la politique ontarienne de dépistage anténatal du VIH. Quatre-vingt-cinq p. cent ont indiqué qu’ils proposaient ou administraient un test de sérodiagnostic du VIH à toutes les femmes enceintes. Soixante-six p. cent convenaient que les femmes devraient avoir le choix de se faire tester ou non; les sages-femmes étaient plus favorables que les médecins à un processus de consentement éclairé.
Conclusion: La connaissance des risques et des avantages du dépistage anténatal du VIH doit être améliorée, et les normes de consentement éclairé devraient être réévaluées afin d’en arriver au processus le plus conforme à l’éthique et le moins complexe possible.
Footnotes
This study was supported by the AIDS Bureau, Ontario Ministry of Health and Long-Term Care
References
- 1.Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer S e al. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society- USA Panel. JAMA. 2000;283:381–90. doi: 10.1001/jama.283.3.381. [DOI] [PubMed] [Google Scholar]
- 2.Ioannidis JP, Abrams EJ, Ammann A, Bulterys M, Goedert JJ, Gray L e al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis. 2001;183:539–45. doi: 10.1086/318530. [DOI] [PubMed] [Google Scholar]
- 3.Silversides A. With HIV prevalence among women increasing, more provinces encourage prenatal testing. CMAJ. 1998;158:1518–19. [PMC free article] [PubMed] [Google Scholar]
- 4.Silversides A. Ontario joins prenatal HIV-screening movement. CMAJ. 1999;160:173–74. [PMC free article] [PubMed] [Google Scholar]
- 5.Health Canada. HIV/AIDS Epi Updates. Ottawa, ON: Division of HIV/AIDS Epidemiology and Surveillance, Bureau of HIV/AIDS, STD and TB; 2001. [Google Scholar]
- 6.Remis R, Major C, Wallace E, Schiedel L, Whittingham EP. Report on HIV/AIDS in Ontario 1997–1998. Toronto, ON: Ontario Ministry of Health and Long-Term Care; 1999. [Google Scholar]
- 7.Bitnun A, King S, Arneson C, Read S. Failure to prevent perinatal HIV infections in Ontario despite universal prenatal HIV counseling and voluntary testing guidelines. CMAJ. 2002;166:904–5. [PMC free article] [PubMed] [Google Scholar]
- 8.Hawken J, Chard T, Jeffries DJ, Costeloe K, Grant K, Ward F e al. Evaluation of an antenatal HIV testing programme in an inner London health district. Br J Obstet Gynaecol. 1994;101:960–64. doi: 10.1111/j.1471-0528.1994.tb13040.x. [DOI] [PubMed] [Google Scholar]
- 9.Ellerbrock TV, Lieb S, Harrington PE, Bush TJ, Schoenfisch SA, Oxtoby M e al. Heterosexually transmitted human immunodeficiency virus infection among pregnant women in a rural Florida community. N Engl J Med. 1992;327:1704–709. doi: 10.1056/NEJM199212103272402. [DOI] [PubMed] [Google Scholar]
- 10.Fehrs LJ, Hill D, Kerndt PR, Rose TP, Henneman C. Targeted HIV screening at a Los Angeles prenatal/family planning health center. Am J Public Health. 1991;81:619–22. doi: 10.2105/AJPH.81.5.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lindsay MK, Peterson HB, Feng TI, Slade BA, Willis S, Klein L. Routine antepartum human immunodeficiency virus infection screening in an inner-city population. Obstet Gynecol. 1989;74:289–94. [PubMed] [Google Scholar]
- 12.Landesman S, Minkoff H, Holman S, McCalla S, Sijin O. Serosurvey of human immunodeficiency virus infection in parturients. Implications for human immunodeficiency virus testing programs of pregnant women. JAMA. 1987;258:2701–703. doi: 10.1001/jama.1987.03400190083032. [DOI] [PubMed] [Google Scholar]
- 13.Barbacci MB, Dalabetta GA, Repke JT, Talbot BL, Charache P, Polk B e al. Human immunodeficiency virus infection in women attending an inner-city prenatal clinic: Ineffectiveness of targeted screening. Sex Transm Dis. 1990;17:122–26. doi: 10.1097/00007435-199007000-00002. [DOI] [PubMed] [Google Scholar]
- 14.Barbacci M, Repke JT, Chaisson RE. Routine prenatal screening for HIV infection. Lancet. 1991;337:709–11. doi: 10.1016/0140-6736(91)90286-X. [DOI] [PubMed] [Google Scholar]
- 15.Cliffe S, Tookey PA, Nicoll A. Antenatal detection of HIV: National surveillance and unlinked anonymous survey. BMJ. 2001;323:376–77. doi: 10.1136/bmj.323.7309.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ogilvie G, Adsett S, Macdonald G. Do physicians discuss HIV testing during prenatal care? Can Fam Phys. 1997;43:1376–81. [PMC free article] [PubMed] [Google Scholar]
- 17.MacDonald SE, Hartling LA, Seguin RM, O’Connor KS, Rekart ML, Mowat D e al. Screening for HIV during pregnancy. Can Fam Phys. 2001;47:2250–57. [PMC free article] [PubMed] [Google Scholar]
- 18.Whittet S. General practitioners' attitudes and beliefs on antenatal testing for HIV: postal questionnaire survey. BMJ. 2000;321(7266):934–934. doi: 10.1136/bmj.321.7266.934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Roome A, Carley K, Melchreit R, Foye G, Hadler J. Testing pregnant women for HIV: A survey of obstetricians and review of patient prenatal/obstetric medical records—Connecticut 1996–1997. Conn Med. 1999;63:523–29. [PubMed] [Google Scholar]
- 20.Chambers ST, Heckert KA, Bagshaw S, Ussher J, Birch M, Wilson MA. Maternity care providers’ attitudes and practices concerning HIV testing during pregnancy; results of a survey of the Canterbury and upper South Island region. N Z Med J. 2001;114:513–16. [PubMed] [Google Scholar]
- 21.Samson L, King S. Evidence-based guidelines for universal counselling and offering of HIV testing in pregnancy in Canada. CMAJ 1998;158:1449-57. [PMC free article] [PubMed]
- 22.Mollart L. A weight off my mind: The abandonment of routine antenatal weighing a change of practice research. J Aust Coll Midwives. 1999;12:26–31. doi: 10.1016/S1031-170X(99)80009-9. [DOI] [PubMed] [Google Scholar]
- 23.Sanders J, Somerset M, Jewell D, Sharp D. To see or not to see? Midwives’ perceptions of reduced antenatal attendances for ‘low-risk’ women. Midwifery. 1999;15:257–63. doi: 10.1054/midw.1999.0183. [DOI] [PubMed] [Google Scholar]
- 24.Leonard L, Shap L. Canadian HIV/AIDS Policy & Law Newsletter. 1999. Pregnancy and HIV/AIDS: A different kind of risk? Pregnant women’s experience of HIV testing in pregnancy; pp. 18–21. [PubMed] [Google Scholar]
- 25.Jepson RG, Forbes CA, Sowden AJ, Lewis RA. Increasing informed uptake and non-uptake of screening: Evidence from a systematic review. Health Expect. 2001;4:116–26. doi: 10.1046/j.1369-6513.2001.00143.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Summers AM. Informed choice in prenatal screening. Can Fam Phys. 1994;40:1688–89. [PMC free article] [PubMed] [Google Scholar]
- 27.Austoker J. Gaining informed consent for screening. Is difficult—but many misconceptions need to be undone. BMJ. 1999;319:722–23. doi: 10.1136/bmj.319.7212.722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Marteau TM. Towards informed decisions about prenatal testing: A review. Prenat Diagn. 1995;15:1215–26. doi: 10.1002/pd.1970151304. [DOI] [PubMed] [Google Scholar]
- 29.Larsson G, Spangberg L, Lindgren S, Bohlin AB. Screening for HIV in pregnant women: A study of maternal opinion. AIDS Care. 1990;2:223–28. doi: 10.1080/09540129008257734. [DOI] [PubMed] [Google Scholar]
- 30.Simpson WM, Johnstone FD, Boyd FM, Goldberg DJ, Hart GJ, Prescott RJ. Uptake and acceptability of antenatal HIV testing: Randomised controlled trial of different methods of offering the test. BMJ. 1998;316:262–67. doi: 10.1136/bmj.316.7127.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Remis R, Guenter D, King S. Testing pregnant women in Canada for HIV: How are we doing? Can Fam Phys. 2001;47:2193–95. [PMC free article] [PubMed] [Google Scholar]
- 32.Revised recommendations for HIV screening of pregnant women. MMWR Recomm Rep. 2001;50(RR-19):63–85. [PubMed] [Google Scholar]
